Clinical Trials
3 trialsNCT01868269 2025-02-03
Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
Institut Curie
Phase 3 Completed
NCT00202930 2021-01-22
Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
University of Pittsburgh
Phase 2 Terminated
NCT00244361 2011-05-10
Effectiveness of Rituximab in Pediatric OMS Patients.
National Pediatric Neuroinflammation Organization, Inc.
Phase 1/2 Completed